Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Endpoints and Quality

Patricia Keegan

MD

🏢US Food and Drug Administration (historical)🌐USA

Former Director, Division of Oncology Products

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Patricia Keegan served as Director of the Division of Oncology Products at the FDA and played a central role in the review of numerous pivotal oncology approvals. She has contributed to endpoint methodology for biologics and immune therapies. Her work has shaped regulatory standards for oncology trial conduct.

Share:

🧪Research Fields 研究领域

oncology regulation
trial endpoints
FDA review
biologics
drug approval

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Patricia Keegan 的研究动态

Follow Patricia Keegan's research updates

留下邮箱,当我们发布与 Patricia Keegan(US Food and Drug Administration (historical))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment